Skip to main content

Advertisement

SpringerLink
Log in

The frequency of the BLM*p.Q548X (c.1642C > T) mutation in breast cancer patients from Russia

  • Rebuttal Letter
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Anisimenko MS, Kozyakov AE, Paul GA, Kovalenko SP (2014) The frequency of the BLM p.Q548X (c.1642C > T) mutation in breast cancer patients from Russia is no higher than in the general population. Breast Cancer Res Treat. doi:10.1007/s10549-014-3187-0

  2. Sokolenko AP, Iyevleva AG, Preobrazhenskaya EV, Mitiushkina NV, Abysheva SN, Suspitsin EN, Kuligina ESh, Gorodnova TV, Pfeifer W, Togo AV, Turkevich EA, Ivantsov AO, Voskresenskiy DV, Dolmatov GD, Bit-Sava EM, Matsko DE, Semiglazov VF, Fichtner I, Larionov AA, Kuznetsov SG, Antoniou AC, Imyanitov EN (2012) High prevalence and breast cancer predisposing role of the BLM c.1642 C > T (Q548X) mutation in Russia. Int J Cancer 130:2867–2873

    Article  CAS  PubMed  Google Scholar 

  3. Prokofyeva D, Bogdanova N, Dubrowinskaja N, Bermisheva M, Takhirova Z, Antonenkova N, Turmanov N, Datsyuk I, Gantsev S, Christiansen H, Park-Simon TW, Hillemanns P, Khusnutdinova E, Dörk T (2013) Nonsense mutation p. Q548X in BLM, the gene mutated in Bloom’s syndrome, is associated with breast cancer in Slavic populations. Breast Cancer Res Treat 137(2):533–539

    Article  CAS  PubMed  Google Scholar 

  4. CHEK2 Breast Cancer Case-Control Consortium (2004) CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. Am J Hum Genet 74(6):1175–1182

    Article  Google Scholar 

  5. Renwick A, Thompson D, Seal S, Kelly P, Chagtai T, Ahmed M, North B, Jayatilake H, Barfoot R, Spanova K, McGuffog L, Evans DG, Eccles D, Breast Cancer Susceptibility Collaboration (UK), Easton DF, Stratton MR, Rahman N (2006) ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet 38(8):873–875

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. N.N. Petrov Institute of Oncology, Saint Petersburg, Russia

    Evgeny Imyanitov

  2. St.-Petersburg State Pediatric Medical University, Saint Petersburg, Russia

    Evgeny Imyanitov

  3. Institute of Biochemistry and Genetics, Ufa Science Center, Ufa, Russia

    Darya Prokofyeva

  4. N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus

    Natalia Bogdanova

  5. Radiation Oncology Research Laboratories, Hannover Medical School, Hannover, Germany

    Natalia Bogdanova

  6. Gynaecology Research Unit, Hannover Medical School, Hannover, Germany

    Thilo Dörk

  7. I.I. Mechnikov North-Western Medical University, Saint Petersburg, Russia

    Evgeny Imyanitov

Authors
  1. Evgeny Imyanitov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Darya Prokofyeva
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Natalia Bogdanova
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Thilo Dörk
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thilo Dörk.

Additional information

This rebuttal letter refers to the letter to the editor article available at 10.1007/s10549-014-3187-0.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Imyanitov, E., Prokofyeva, D., Bogdanova, N. et al. The frequency of the BLM*p.Q548X (c.1642C > T) mutation in breast cancer patients from Russia. Breast Cancer Res Treat 148, 695–696 (2014). https://doi.org/10.1007/s10549-014-3198-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-014-3198-x

Keywords

Search

Navigation